![](/img/cover-not-exists.png)
A Phase II Prospective, Randomized, DoubleâBlind , PlaceboâControlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone ReceptorâPositive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
SánchezâRovira, Pedro, Hirschberg, Angelica Lindén, GilâGil, Miguel, BermejoâDe Las Heras, Begoña, NietoâMagro, ConcepciónJournal:
The Oncologist
DOI:
10.1634/theoncologist.2020-0417
Date:
May, 2020
File:
PDF, 702 KB
2020